Risk factors of unfavorable prognosis of chronic hepatitis C

Risk factors of unfavorable prognosis of chronic hepatitis C

Aim. To investigate risk factors of unfavorable prognosis in patients with chronic hepatitis C (CHC), including liver cirrhosis (LC), decompensated cirrhosis, hepatocellular carcinoma (HCC), cryoglobulinemic vasculitis (CryoVas) and B-cell non-Hodgkin’s lymphoma. Materials and methods. This was a re...

Full description

Bibliographic Details
Main Authors:	S E Shchanitcyna, E Z Burnevich, E N Nikulkina, A L Filatova, S V Moiseev, N A Mukhin
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2019-02-01
Series:	Терапевтический архив
Subjects:	chronic hepatitis c liver cirrhosis decompensation of cirrhosis hepatocellular carcinoma cryoglobulinemic vasculitis b-cell lymphome predictors risk factors
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/32932/pdf

Similar Items

CRYOGLOBULINEMIC VASCULITIS ASSOCIATED WITH HBV INFECTION: CLINICAL OBSERVATIONS AND LITERATURE REVIEW
by: N. V. Dunaeva, et al.
Published: (2014-08-01)

Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients
by: Kei Moriya, et al.
Published: (2019-12-01)

The Impact of Previous Acute Decompensation on the Long-Term Prognosis of Alcoholic Hepatitis in Cirrhotic Patients
by: Eileen L. Yoon, et al.
Published: (2019-10-01)

HCV-ASSOCIATED CRYOGLOBULINEMIC VASCULITIS
by: V I Vasiliev, et al.
Published: (2012-05-01)

Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis
by: Sahaj Rathi, et al.
Published: (2021-01-01)

Hepatitis C virus-related cryoglobulinemic vasculitis with renal involvement: current possibilities of treatment
by: N B Gordovskaia, et al.
Published: (2013-06-01)

Combination with portosystemic shunt occlusion and antiviral therapy improves prognosis of decompensated cirrhosis
by: Hideyuki Tamai, et al.
Published: (2020-08-01)

Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy
by: Chih-Lin Lin, et al.
Published: (2020-10-01)

POLYMORPHISM OF CLINICAL MANIFESTATIONS OF CRYOGLOBULINEMIA-RELATED VASCULITIS ASSOCIATED WITH CHRONIC HEPATITIS С VIRUS INFECTION
by: S. Yu. Milovanova, et al.
Published: (2016-02-01)

Clinical-evolutional particularities of the cryoglobulinemic vasculitis in the case of a patient diagnosed with hepatitis C virus in the predialitic phase
by: Daniel C. Caragea, et al.
Published: (2018-04-01)

Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma
by: T M Ignatova, et al.
Published: (2012-11-01)

Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection – a systematic review
by: Laura Llamosas-Falcón, et al.
Published: (2020-06-01)

Hepatitis B infection: review article
by: Jafar Mohammadshahi, et al.
Published: (2018-12-01)

Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment
by: T M Ignatova, et al.
Published: (2017-05-01)

Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C
by: Huiying Rao, et al.
Published: (2020-08-01)

Cryoglobulinemic vasculitis in chronic hepatitis C: Genetic aspects
by: M G Artemova, et al.
Published: (2017-04-01)

Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? – Treatment of Patients with Decompensated Cirrhosis
by: Geum-Youn Gwak
Published: (2016-03-01)

Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
by: Fu-Shun Yen, et al.
Published: (2021-06-01)

The economic burden of advanced liver disease among patients with Hepatitis C Virus: a large state Medicaid perspective
by: Menzin Joseph, et al.
Published: (2012-12-01)

Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience
by: Eun Ju Cho, et al.
Published: (2012-06-01)

Plasma diamine oxidase level predicts 6-month readmission for patients with hepatitis B virus-related decompensated cirrhosis
by: Feng-Cai Li, et al.
Published: (2019-09-01)

Predictors of minimal hepatic encephalopathy in patients with cirrhosis
by: Sharma Praveen, et al.
Published: (2010-01-01)

Step by Step: Managing the Complications of Cirrhosis
by: Perez IC, et al.
Published: (2021-05-01)

Two cases with liver cirrhosis secondary to hepatitis B that presented with hepatocellular carcinoma at young age
by: Ahmet Uyanıkoğlu, et al.
Published: (2013-03-01)

Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosis
by: S N Batskikh, et al.
Published: (2018-11-01)

Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days
by: Xiaomei Xu, et al.
Published: (2021-05-01)

USE OF RITUXIMAB IN PATIENTS WITH SYSTEMIC MANIFESTATIONS OF PRIMARY SJOGREN'S SYNDROME
by: O. A. Logvinenko, et al.
Published: (2014-12-01)

Hepatic Hydrothorax—An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis
by: Daniela Matei, et al.
Published: (2021-08-01)

Substernal Mass: A Rare Presentation of Hepatocellular Carcinoma
by: Kevin Yuqi Wang, et al.
Published: (2019-11-01)

Severe acute alcoholic hepatitis and liver transplant: A never-ending mournful story
by: Aiman Obed, et al.
Published: (2018-12-01)

Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study
by: Filomena Morisco, et al.
Published: (2021-07-01)

Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia
by: Clodoveo Ferri, et al.
Published: (2017-07-01)

Predictors of hepatocellular carcinoma in patients with liver cirrhosis
by: Pop Crina, et al.
Published: (2015-03-01)

Spontaneous bacterial peritonitis in a 45-year-old man with ethanolic liver cirrhosis
by: Roxana Mirică, et al.
Published: (2020-06-01)

Hepatocellular carcinoma in a hepatitis C patient with sustained viral response and no fibrosis
by: James H. Tabibian, et al.
Published: (2009-01-01)

Simeprevir in combination with pegylated interferon-α and ribavirin in the treatment of naïve patients with genotype 1 chronic hepatitis C
by: É Z Burnevich
Published: (2014-11-01)

Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir
by: Seung Bum Lee, et al.
Published: (2020-07-01)

A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management
by: Julio D. Vorobioff, et al.
Published: (2020-07-01)

Epidemiología molecular del virus de la hepatitis C
by: Karina Salvatierra

A Case of Composite Hepatocellular Carcinoma and Neuroendocrine Carcinoma in a Patient with Liver Cirrhosis Caused by Chronic Hepatitis B
by: Eun Young Yun, et al.
Published: (2016-08-01)